SCI期刊
首頁 略過巡覽連結首頁 分隔符號 最新消息 分隔符號 SCI期刊   
SCI期刊

3.   Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes.  2019.06.03
 

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes.

Chang CC, Chen CY, Chang GD, Chen TH, Chen WL, Wen HC, Huang CY, Chang CH

Abstract


Aging is characterized by mild hyperglycemia and accumulation of advanced glycation end products (AGEs). Effects of chronic exposure to hyperglycemia or AGEs on the adipogenic differentiation of 3T3-L1 preadipocytes remain unclear. We examined the chronic effect of AGEs and high glucose on the differentiation of 3T3-L1 cells by culturing 3T3-L1 cells in the presence of AGEs or 25 mM glucose for 1 month. Chronic incubation of 3T3-L1 cells with AGEs or high glucose blocked their differentiation into mature adipocytes as evidenced by reduced levels of adipocyte markers such as accumulated oil droplets, GPDH, aP2, adiponectin and of adipogenesis regulators PPARγ and C/EBPα. Levels or activities of Src, PDK1, Akt, and NF-κB were higher in AGEs- and high glucose-treated cells than those in 3T3-L1 cells. Levels of Bcl-2 were elevated in AGEs- and high glucose-treated cells, and were attenuated by inhibitors of PI3-kinase, Akt and NF-κB. Moreover, adipogenesis was attenuated in 3T3-L1 cells stably expressing Bcl-2 or YAP. These results suggest that chronic AGEs and high glucose treatments up-regulate Bcl-2 and YAP via the Akt-NF-κB pathway and impair adipogenesis.

Oncotarget 2017;8(33):55039-50
https://www.ncbi.nlm.nih.gov/pubmed/28903400


 返回上頁

彰化基督教醫院 腎腎臟科醫學中心(回彰基首頁)
© 2009 Changhua Christian Hospital All Rights Reserved. 隱私權宣告
本站提供之資訊僅供參考,不能取代醫師及醫療專業人員之當面評估或治療
網站維護 : 慢性腎臟病衛教中心 網站負責人:黃智英 護理師
RSS  瀏覽人次 3898553  線上人數 14人  最後更新時間: 2021.03.08
全家人的健康保障 A+